Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 2.05% in a Single Session

Circuit Event and Unfilled Supply

The stock, trading in the BE series, declined by 2.05% on the day, hitting the lower circuit band of 5%. This price band capped the daily loss at 5%, which is typical for stocks in this segment. The closing price of Rs 1,681.4 represents the floor price where trading was effectively halted due to a lack of buyers willing to absorb the supply. This unfilled supply scenario is a hallmark of lower circuit events, especially in micro-cap stocks like Venus Remedies Ltd, where liquidity is thinner and exit pressures can intensify rapidly. The total traded volume was 0.22203 lakh shares, with a turnover of Rs 3.85 crore, indicating that despite the circuit lock, some trades did execute but the bulk of selling interest remained unmet. How deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes on 19 Aug fell sharply by 71.34% compared to the 5-day average, with only 1,600 shares delivered. This decline in delivery volume on a lower circuit day suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. Typically, rising delivery volumes on a lower circuit day indicate holders are offloading actual shares, signalling capitulation or forced selling. However, in this case, the falling delivery volume points to a different dynamic where intraday traders might be driving the price down without substantial transfer of ownership. The weighted average price was closer to the high price of Rs 1,783.9, indicating that most volume traded near the upper end of the day’s range before the stock cascaded down to the circuit floor. Is this a capitulation or just speculative pressure that might ease soon?

Intraday Price Action

The intraday range was from a high of Rs 1,783.9 to the low circuit price of Rs 1,681.4, representing a 5.7% swing within the session. The stock opened near the high price and gradually declined throughout the day, eventually locking at the circuit floor. This gradual descent rather than a sudden gap-down suggests persistent selling pressure that overwhelmed demand over the session. The fact that the weighted average price was closer to the high indicates that early trades were executed at higher levels before the supply imbalance intensified. Does the intraday arc reveal exhaustion or the start of a deeper downtrend?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day moving average but remains above the 20-day, 50-day, 100-day, and 200-day moving averages. This mixed moving average configuration suggests short-term weakness but no confirmed longer-term downtrend. The dip below the 5-day MA signals immediate selling pressure, but the stock has yet to breach the more significant longer-term averages that typically indicate sustained weakness. Does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of approximately Rs 2,390 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with a trade size capacity of Rs 0.18 crore based on 2% of the 5-day average traded value. While this suggests some ability to transact, the lower circuit lock highlights the exit risk inherent in micro-cap stocks — sellers who want to exit at these levels face difficulty finding buyers, potentially leading to multi-day circuit locks. This liquidity constraint compounds the selling pressure, as the exchange’s circuit mechanism freezes the price, trapping sellers on the wrong side of the market. How significant is the liquidity exit risk for Venus Remedies and what might it mean for trading ahead?

Fundamental Context

Operating in the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd has demonstrated a consistent growth trajectory and maintains a strong fundamental track record. Despite the recent price weakness, the company’s micro-cap status means that market movements can be amplified by liquidity constraints rather than fundamental deterioration alone.

Conclusion: Severity Assessment and Liquidity Caveats

The 5% lower circuit lock for Venus Remedies Ltd reflects a session where supply overwhelmed demand to the point that the exchange’s circuit breaker intervened. The falling delivery volume suggests speculative selling rather than wholesale liquidation, but the micro-cap status and moderate liquidity mean that sellers face meaningful exit friction. The stock’s position below the 5-day moving average confirms short-term weakness, though longer-term averages have yet to be breached. The intraday price action, with a gradual decline from Rs 1,783.9 to the circuit floor at Rs 1,681.4, indicates persistent selling pressure rather than a sudden shock. After a 2.05% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →